compasspathways.com (CMPS) Earnings growth forecast for next year

Compass Pathways - graphic logo of issuer CMPS

The projected net profit growth of COMPASS Pathways plc (CMPS) reflects the market consensus, where 8.30 forms the current metric. The company's economic moat is built on patents for psychedelics used to treat depression. Operational efficiency is driven by the diversification of supply chains for specialized centers. The secure delivery of medications is guaranteed by strict government oversight and protected transportation methods.

COMPASS Pathways PLC (CMPS): Expected net earnings per share growth next year from 07/04/2022 to 11/10/2026

Metric breakdowns and analytics for compasspathways.com (CMPS)

- share price and consensus valuation forecast:
Stock Price Compass Pathways|CMPS - Consensus Target
- market capitalization details:
Market Capitalization COMPASS Pathways|CMPS - Value Adjusted for Debt and Cash
- book capitalization indicators:
Net Assets per Single Share COMPASS Pathways|CMPS - Total Stockholders' Equity|Market Capitalization to Book Value Ratio compasspathways.com|CMPS - Cumulative Company Assets
- company total debt and liquidity indicators:
Debt to Equity COMPASS Pathways plc|CMPS - Long-Term Liabilities to Capital|Short-Term Debt to Equity COMPASS Pathways|CMPS - Company Total Debt|Debt to Book Capitalization Ratio COMPASS Pathways|CMPS - Long-Term Liabilities|Company Short-Term Debts COMPASS Pathways|Quick Liquidity compasspathways.com
- net income and valuation ratios data:
CMPS - Net Financial Result|Expected Profit COMPASS Pathways plc|CMPS - Business Payback Period|Projected Price to Earnings COMPASS Pathways plc|CMPS - Growth-Adjusted Payback Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization COMPASS Pathways|CMPS - Profit before deduction of interest, taxes, depreciation and amortization|Net earnings per share (EPS TTM) COMPASS Pathways|CMPS - Net earnings per share (EPS TTM)|Year-over-year net earnings per share growth for the last 12 months compasspathways.com|CMPS - Net earnings per one share growth for the current year|Earnings growth forecast for next year COMPASS Pathways plc
Comprehensive company analysis:CMPS, Compass Pathways
Core merchandise of COMPASS Pathways

For COMPASS Pathways plc (CMPS), the current EPS growth forecast for the next period reflects market expectations regarding the pace of profit scaling. This indicator captures the trend of analyst consensus forecasts, where rising values confirm the strengthening of fundamental valuation metrics. The metric's sensitivity to estimate revisions depends directly on the success of the commercialization of psilocybin-based therapy. A downward trend signals risks of inefficient investment in drug development.

Who COMPASS Pathways plc competes with

ALKS (Alkermes Inc.) - Earnings growth forecast for next year|Expected earnings per share growth for next year Avadel Corp (AVDL)|Earnings growth forecast for next year ATAI|GHRS (ghres.com) - Expected earnings per share trend next year|Net earnings per share growth forecast for next year MindMed MNMD|LB Pharmaceuticals, Inc. (LBRX) - Expected net earnings per share growth next year|Bright Minds Biosciences Inc - Earnings growth forecast for next year|Vanda (VNDA) - Expected earnings per share growth for next year|cybin.com (CYBN) - Net earnings per share growth forecast for next year|Expected net earnings per share growth next year altoneuroscience.com (ANRO)|Net earnings per share growth forecast for next year NRx Pharmaceuticals, Inc.|Expected earnings per share growth for next year Cingulate Corp (CING)|Net earnings per share growth forecast for next year Silo Pharma, Inc. (SILO)|CPHI: Net earnings per share change forecast for next year|Earnings growth forecast for next year CMND (Clearmind Medicine)|Earnings growth forecast for next year pacificbayminerals.com PBM|SPRC - Net earnings per share growth forecast for next year|Consensus forecast of earnings per share growth for next year Seelos Therapeutics Inc. SEEL|virpaxpharma.com (VRPX) - Net earnings per share growth forecast for next year|KRTX - Consensus forecast of earnings per share growth for next year